Aratana Therapeutics Inc. (PETX) Stock Price, Forecast & Analysis
USA - NASDAQ:PETX -
PETX Key Statistics, Chart & Performance
The current stock price of PETX is 4.92 null. In the past month the price increased by 0.61%. In the past year, price increased by 9.82%.
PETX Latest News, Press Relases and Analysis
About PETX
Company Profile
Aratana Therapeutics Inc. is a biopharmaceutical company for animals. The Company is developing compounds for the pet health market, including a non-COXIB analgesic for treating pain, an appetite-stimulating molecule for inappetence and licensed non-opioid local anesthetic for treating post-operative pain. It operates in the United States and Europe. Aratana Therapeutics Inc. is headquartered in Kansas City, Kansas.
Company Info
Aratana Therapeutics Inc.
11400 TOMAHAWK CREEK PARKWAY SUITE 340
LEAWOOD KS 66211
CEO: Craig A. Tooman
Phone: 913-353-1000
Aratana Therapeutics Inc. / PETX FAQ
What does Aratana Therapeutics Inc. do?
Aratana Therapeutics Inc. is a biopharmaceutical company for animals. The Company is developing compounds for the pet health market, including a non-COXIB analgesic for treating pain, an appetite-stimulating molecule for inappetence and licensed non-opioid local anesthetic for treating post-operative pain. It operates in the United States and Europe. Aratana Therapeutics Inc. is headquartered in Kansas City, Kansas.
What is the current price of PETX stock?
The current stock price of PETX is 4.92 null. The price decreased by -0.2% in the last trading session.
Does PETX stock pay dividends?
PETX does not pay a dividend.
What is the ChartMill rating of Aratana Therapeutics Inc. stock?
PETX has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Which stock exchange lists PETX stock?
PETX stock is listed on the Nasdaq exchange.
PETX Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to PETX. When comparing the yearly performance of all stocks, PETX is one of the better performing stocks in the market, outperforming 93.61% of all stocks.
PETX Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to PETX. PETX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
PETX Financial Highlights
Over the last trailing twelve months PETX reported a non-GAAP Earnings per Share(EPS) of -0.27. The EPS increased by 68.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -33.47% | ||
| ROA | -12.38% | ||
| ROE | -13.47% | ||
| Debt/Equity | 0 |